AAAAAA

   
Results: 1-5 |
Results: 5
Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease
Authors: de Lima, M Bonamino, M Vasconcelos, Z Colares, M Diamond, H Zalcberg, I Tavares, R Lerner, D Byington, R Bouzas, L da Matta, J Andrade, C Carvalho, L Pires, V Barone, B Maciel, C Tabak, D
Citation: M. De Lima et al., Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease, BONE MAR TR, 27(1), 2001, pp. 73-78
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials
Authors: Neal, B MacMahon, S Chapman, N Cutler, J Fagard, R Neal, B Whelton, P Yusuf, S Agodoa, L Baigent, C Black, H Boissel, JP Brenner, B Brown, M Bulpitt, C Byington, R Chalmers, J Collins, R Dahlof, B Davis, B Estacio, R Fox, K Hansson, L Holman, R Hunsicker, L Kostis, J Kuramoto, K Kusek, J Lees, R Lewis, E Lindholm, LH Liu, L Lubsen, J Malacco, E Mancia, G Martin, I Pepine, C Pfeffer, M Pitt, B Poole-Wilson, P Remuzzi, G Rodgers, A Ruggenenti, P Schrier, R Sever, P Sleight, P Staessen, J Teo, K Turner, R Wing, L Zanchetti, A Algert, C Woodward, M
Citation: B. Neal et al., Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials, LANCET, 356(9246), 2000, pp. 1955-1964
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors - The prospective pravastatin pooling project
Authors: Sacks, FM Tonkin, AM Shepherd, J Braunwald, E Cobbe, S Hawkins, CM Keech, A Packard, C Simes, J Byington, R Furberg, CD
Citation: Fm. Sacks et al., Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors - The prospective pravastatin pooling project, CIRCULATION, 102(16), 2000, pp. 1893-1900
Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States andCanada
Authors: Miller, M Byington, R Hunninghake, D Pitt, B Furberg, CD
Citation: M. Miller et al., Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States andCanada, ARCH IN MED, 160(3), 2000, pp. 343-347
Toward better therapy at hypercholesterolemia - Reply
Authors: Miller, M Byington, R
Citation: M. Miller et R. Byington, Toward better therapy at hypercholesterolemia - Reply, ARCH IN MED, 160(17), 2000, pp. 2686-2686
Risultati: 1-5 |